preeclampsia. o14
Conditions
Interventions
Intervention 1: Intervention group: In intervention group number one, which includes receiving hydralazine. 5 mg of this drug will be slowly injected intravenously and to blind the samples in this gro
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant women 18 to 45 years old Gestational age greater than or equal to 20 weeks Blood pressure greater than or equal to 160 over 110
Exclusion criteria
Exclusion criteria: Maternal disease of any kind, including heart (heart arrhythmia - heart failure - chest pain, etc.), kidney, liver Fetal disorders including intrauterine growth restriction (IUGR) and Oligohydramnios Uncertain patterns of fetal heart rate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: At the beginning of the study, then every twenty minutes until the blood pressure drops. Method of measurement: Using electronic blood pressure monitoring device.;Diastolic blood pressure. Timepoint: At the beginning of the study, then every twenty minutes until the blood pressure drops. Method of measurement: Using electronic blood pressure monitoring device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Average blood pressure. Timepoint: At the beginning of the study, then every twenty minutes until the blood pressure drops. Method of measurement: Using electronic blood pressure monitoring device.;Time to achieve controlled blood pressure. Timepoint: At the beginning of the study, then every twenty minutes. Method of measurement: Used in hours and in minutes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Yari
Khoram-Abad University of Medical Sciences
Outcome results
None listed